Ontario expands use of biosimilar drug treatments
By Susan Yellin | Dec. 26, 2022, 9:53 a.m.
Photo: Unsplash | Laurynas Mereckas
Ontario Drug Benefit recipients who are on an originator biologic will begin to transition to a Health Canada approved biosimilar version of the drug at the end of March.
This article is reserved to PRO Level subscribers
The most popular in Health
Related topics …